IP Library Assignment 018109/0614
Patent Assignment
Reel/Frame 018109/0614

Change of Name

Recorded: 2006-08-14 Pages: 4
Assignor
SYN X PHARMA INC.
Executed: 2006-02-09
Assignee
NANOGEN POINT OF CARE INC.
1 MARMAC DRIVE, TORONTO, ONTARIO, M9W 1E7, CANADA
Covered Property (1)
Process for Determining the Presence of Monomeric Brain Associated Human Glutamine Synthetase in Patients Exhibiting Mild Cognitive Impairment
Patent: 7,070,945 →
Application: 10/246,383 →
Publication: US 2003/0064416
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 20, 2002
From: JACKOWSKI, GEORGE; TAKAHASHI, MIYOKO
To: SYN X PHARMA, INC.
Reel/Frame 013524/0095 →
Security Agreement Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
Security Interest Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Assignment of Assignor's Interest Dec 5, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 018584/0272 →
Assignment of Intellectual Property Security Agreement Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →
Grant of Security Interest Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →